Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-28

FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a generic carbidopa-levodopa product under an Original Application by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

ORIG AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)